1. White Paper AGA: Functional Dyspepsia
- Author
-
Nimish Vakil, Colin W. Howden, Paul Moayyedi, and Jan Tack
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,Treatment outcome ,Gastroenterology ,Alternative medicine ,medicine.disease ,Food and drug administration ,03 medical and health sciences ,0302 clinical medicine ,White paper ,Functional gastrointestinal disorder ,Internal medicine ,Family medicine ,medicine ,030211 gastroenterology & hepatology ,Patient-reported outcome ,030212 general & internal medicine ,business ,Pharmaceutical industry - Abstract
Functional dyspepsia remains a major challenge for clinicians with no approved drugs available in the Western World. In October 2016, a meeting was held in Washington, DC, sponsored by the American Gastroenterological Association's Center for Diagnostics and Therapeutics, which included members of the Food and Drug Administration (FDA) and the pharmaceutical industry, experts in FD, and representatives of patient organizations. This white paper summarizes our current status, progress with a validated patient reported outcome instrument in functional dyspepsia, future directions and needs.
- Published
- 2017